StockNews.com assumed coverage on shares of Cancer Genetics (NASDAQ:CGIX – Free Report) in a research note published on Sunday. The brokerage issued a sell rating on the stock. Cancer Genetics Price Performance NASDAQ CGIX opened at $0.18 on Friday. The stock’s fifty day moving average is $0.17. The firm has a market capitalization of $736,525.50, […]